COVID-19 Tanılı Hastaların Risk Faktörleri Açısından Değerlendirilmesi

Günal, Özgür; Türe, Eda; Bayburtlu, Meryem; Arslan, Uğur; Demirağ, Mehmet Derya; Taşkın, Mehmet Hakan; Kiliç, S. Sırrı

doi:10.5578/mb.69811

Cited by 11 publications

(4 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It was observed that as the mean age of the patients increased, the clinical severity also increased. Many studies demonstrating male gender and advanced age as critical factors on the severity and prognosis of COVID-19 supports our findings ( 5 ). An early study raised concerns about the gendered impacts of the COVID-19 outbreak and it was confirmed by many subsequent studies later on ( 6 , 7 , 8 ).…”

Section: Discussionsupporting

confidence: 90%

Predictors of Severity and Mortality in COVID-19: A Retrospective Study from Batman, Turkey

Akgül¹,

Sevim²,

Arslan³

et al. 2022

Infect Dis Clin Microbiol

View full text Add to dashboard Cite

Objective: It is increasingly important to identify risk factors for COVID-19-associated mortality to provide access to early treatment. This study aimed to investigate the relationship between COVID-19 severity and laboratory data and demographic characteristics of hospitalized patients and to identify factors predicting mortality in COVID-19. Materials and Methods:The study is a retrospective and single-center study. Data of 1298 COVID-19 patients confirmed by a positive real-time polymerase chain reaction test for COVID-19 and treated at the hospital were retrospectively analyzed. Study patients were divided into three groups based on the clinical severity of disease: the mild-moderate group (n:954) and the severe (n:310) and critical (n:34) groups. Demographic characteristics, underlying diseases, and laboratory findings were compared between groups.Results: Multivariate logistic and ordinal logistic regression analysis revealed that male gender, old age, diabetes mellitus, coronary artery disease, cerebrovascular event, malignancy, chronic obstructive pulmonary disease, chronic renal failure, chronic hepatitis B, and Alzheimer's disease/dementia/Parkinson's disease (among neurological diseases) were independently associated with and significantly increased the development of severe disease and mortality. Conclusion:The COVID-19 pandemic continues to be a significant health problem affecting all of humanity. Determining risk factors for COVID-19 severity and mortality are critical for classifying critical cases at the time of initial diagnosis, establishing appropriately specific treatment protocols, and ensuring access to early treatment.

show abstract

Section: Discussionsupporting

confidence: 90%

Predictors of Severity and Mortality in COVID-19: A Retrospective Study from Batman, Turkey

Akgül¹,

Sevim²,

Arslan³

et al. 2022

Infect Dis Clin Microbiol

View full text Add to dashboard Cite

show abstract

“…A US study that included 1526 patients concluded that having asthma did not affect COVID-19 patients' rates of hospitalization or mortality, although the prevalence of asthma was found to be higher in COVID-19 patients than in the non-asthmatic population [20]. A Turkish study of 100 COVID-19 patients did not identify asthma as a risk factor for severe COVID-19 [21].…”

Section: Discussionmentioning

confidence: 98%

How does allergic rhinitis impact the severity of COVID-19?: a case–control study

Güvey¹

2021

Eur Arch Otorhinolaryngol

View full text Add to dashboard Cite

Background Coronavirus disease 2019 (COVID-19) is a contagious disease whose symptoms and risk factors are newly described. Some allergic diseases, including asthma, have been defined as risk factors for a poor outcome in COVID-19. We aimed to investigate the role of another allergic disease—allergic rhinitis—in the severity of COVID-19. Methods This case–control study was conducted at Sakarya Educational and Research Hospital, Toyota Hospital and Yenikent State Hospital between March 18, 2020 and August 30, 2020. The study included a case group of 125 randomly selected patients who had been diagnosed with allergic rhinitis in advance of having COVID-19 and a control group of 125 patients without allergic rhinitis who were diagnosed with COVID-19. We evaluated all participants’ statuses regarding smoking, symptoms, and hospitalization, as well as the length of their hospitalization and the number of their comorbidities. Results There were no statistically significant differences between the two groups regarding percentage of asymptomatic patients ( p = 0.27), presence of smoking ( p = 0.068), hospitalization status ( p = 0.79), and hospitalization length ( p = 0.55). From each group, two patients needed care in an intensive care unit (ICU). One patient from the case group and two from the control group died due to COVID-19. Conclusion We found that allergic rhinitis did not affect the severity of COVID-19. However, we recommend that the literature be augmented with further studies on the COVID-19 prognosis of patients who have allergic rhinitis. Supplementary Information The online version contains supplementary material available at 10.1007/s00405-021-06836-z.

show abstract

“…In other words, contrary to what is known, the rate of COVID-19 diagnosis was found to be high in the individuals in our sample who did not smoke and/or did not have any chronic diseases. We think that the low rate of infection in the patients in our sample aged 65 and over may have occurred due to the frequent emphasis on the warning that they are at risk, as well as the strict social isolation practices imposed upon this age group (12)(13)(14)(15)(16)(17)(18). Studies that reflect different views on the relationship between smoking and the disease have been conducted.…”

Section: Discussionmentioning

confidence: 99%

Patients’ approach to medicines in COVID-19

Zorlu¹,

Bulut²,

HIZMALI³

et al. 2022

JECM

View full text Add to dashboard Cite

Several different guidelines and therapeutic recommendations have been reported for the treatment of COVID-19 since the announcement of the pandemic. In our study, the attitudes and approaches of patients with a medical indication for COVID-19 who were given drugs towards drug usage were evaluated. We aimed to present our data on the drug usage characteristics of patients to contribute to the literature. A total of 399 patients were included in the study. In the study, 51.1% of the patients were female, and 48.9% were male. The highest number of the patients were in the 18-30 age group (27.6%), the lowest number of the patients were 65 years old or older (9.8%). Twenty-five questions prepared by the researchers were asked to the patients to evaluate "their knowledge and attitudes on drug usage and disease prevention in COVID-19." Of the patients, 75.7% were not smokers. No history of chronic disease was present in 65.5% of the patients. It was determined that no drug was recommended for 9.8% of the patients, and hydroxychloroquine and favipiravir were recommended together in 49.9%. The rate of the use of chloroquine alone was 4.8%, and the rate of using only favipiravir was 32.8%. Eighty-two percent of the patients reported that they regularly used the drugs that were recommended. Among the patients, 11.5% either never used the recommended drugs or did not use them at the recommended dose and time. Of the 46 (11.5%) patients who did not use the prescribed drugs regularly, none died. In other words, improvement was observed in the patients who did not use the drugs that were recommended to them. Our aim in this study was to determine the rate and characteristics of the drugs prescribed by physicians in diagnosed patients. In this cross-sectional sample of Turkey, it was determined that the rate of recommended drug usage was sufficient with the data of the city where the study was carried out.

show abstract

COVID-19 Tanılı Hastaların Risk Faktörleri Açısından Değerlendirilmesi

Cited by 11 publications

References 12 publications

Predictors of Severity and Mortality in COVID-19: A Retrospective Study from Batman, Turkey

Predictors of Severity and Mortality in COVID-19: A Retrospective Study from Batman, Turkey

How does allergic rhinitis impact the severity of COVID-19?: a case–control study

Patients’ approach to medicines in COVID-19

Contact Info

Product

Resources

About